DCA seizes overpriced Itraconazole capsules from medical shop in Secunderabad

Hyderabad: The teams of the Telangana State Drug Control Administration (TGSDCA) carried out raids and seized stocks of ITRAMEN-200 capsules (Itraconazole Capsules 200 mg) at a medical shop in Bandimet, Secunderabad.

Itraconazole Capsules 200 mg, sold under brand name ‘ITRAMEN-200 Capsules’, is under price control as per the Drugs (Prices Control) Order, 2013, which is fixed by the National Pharmaceutical Pricing Authority (NPPA).

Itramen-200 Capsules (Itraconazole Capsules 200 mg), manufactured by Rivpra Formulations Pvt Ltd, Haridwar, Uttarakhand, for Menrik Biomerge Pvt Ltd, Manak Vihar, New Delhi, had an MRP of Rs 350 for 10 capsules.

However, the ceiling price fixed by the NPPA is Rs 221.2 for 10 capsules.

The MRP of this drug, including GST of 12 per cent, should not be more than Rs 247.7 for 10 capsules.

The firm, however, overpriced the product and charged an excess of Rs 102.23 for 10 capsules, which is a violation of the Drugs (Prices Control) Order, 2013, the TSDCA officials said.

 

 

Related Posts

  • Pharma
  • May 31, 2025
  • 55 views
47% of pharma MOUs from VGGS 2024 commissioned

Gandhinagar:  The state govt said that 47% of MoUs signed in the pharmaceutical sector in the Vibrant Gujarat Global Summit (VGGS) 2024 have been commissioned. It said on Friday that…

  • Pharma
  • May 30, 2025
  • 92 views
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

47% of pharma MOUs from VGGS 2024 commissioned

47% of pharma MOUs from VGGS 2024 commissioned

I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

AstraZeneca gets CDSCO nod for lung cancer drug

AstraZeneca gets CDSCO nod for lung cancer drug

Anar Modi named CHO at Senores Pharma

Anar Modi named CHO at Senores Pharma